ARTICLE | Company News
Galenea, Eisai deal
July 16, 2012 7:00 AM UTC
Eisai and Galenea partnered to discover and develop synaptic modulators to treat neurodegenerative diseases. The partners will use Galenea's Multiwell Automated Neuro Transmission Assay (Mantra) to id...